ImageneBio IncIMA
Price$4.58

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $800K-77.1% YoYTTM through 30 Jun 2026
Net Income -$52.5MTTM through 30 Jun 2026
Free Cash Flow -$52.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin0.0%
Operating Margin-7,370.1%
Net Margin-6,560.5%

Returns

-36.9%ROE
-34.5%ROA

Balance Sheet Health

Current Ratio21.47x
Net Debt-$109.1Mnet cash position
Cash & Equivalents$94.7M

Quality Metrics

Altman Z-Score0.79
Piotroski F-Score2 / 9
FCF Margin-6,573.3%
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $800K
Diluted EPS-$2.90TTM
'21'22'23'24'25
FY2025: $-9.31

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.